Ablation procedure refers to a minimally invasive surgical procedure which involves either destruction or removal of diseased or unnecessary tissue to cure the disease. It provides successful form of surgical option that has gradually become a popular alternative over invasive procedure amongst physicians and patients. The principal advantage of these procedures over surgery is short recovery time, short length scars, low risk of infection, less blood loss, and shorter hospital stays.
The global ablation devices market was valued at $7.5 billion in 2011 and is poised to grow at a CAGR of 10.5% to reach $12.4 billion by 2016. The ablation market is broadly segmented into two classes, namely, thermal and non-thermal technologies. Thermal segment consists of technologies such as electrical, radiation, light, radiofrequency, ultrasound, microwave, and hydrothermal and non-thermal segment includes cryoablation and hydromechanical. Ablation devices have applications in myriad clinical areas such as cancer / tumor, cardiac, ophthalmology, urology, gynecology and orthopedics.
Ablation procedures have witnessed significant growth in the recent years, which are attributable to factors such as growing healthcare expenditure, favorable demographics and cost effectiveness over tradition surgical procedures. Moreover, increasing applications in cancer and cardiac segment are fueling the market growth.
Factors such as advancements in technology, increasing demand for minimally invasive surgical procedures, growing baby boomers population (especially in U.S., Japan and Western European countries) are driving the market. The incidence cases of chronic diseases is expected to rise continuously in the coming years, because with increasing age, the risk of developing chronic diseases such as cancer, cardiovascular disorders, gynaecological, and orthopaedic problems increases. The ablation devices market for treating these diseases would show significant growth in the forecast period. The principal advantage of ablation procedures over surgery is short recovery time, short surgical timelines, low risk of infection, minimal damage to the healthy tissue, less blood loss, and shorter hospital stays.
Radiation therapy accounted for the largest share of 41% of the total ablation technologies market in 2011. The major driver of radiation therapy is the fact that it is applicable to any form of cancer ranging from soft tissue such as liver, lungs to bone metastases. Compared to most other techniques, radiation therapy is considered to be effective in all cancer scenarios, thus it is a single treatment for control of cancer used by most radiologists. It is expected that, radiation therapy devices will continue to enjoy the majority share in the ablation devices market for at least another decade owing to its broad scope of use, different methods of application, stable acceptance in population, and high level of awareness as compared to newly introduced ablation techniques such as hydrothermal, microwave and hydromechanical ablation.
Americas is the biggest market for ablation devices, followed by Europe. However, Asian countries represent the fastest growing markets and factors such as high patient pool, growing preferences to MIS, geographical expansion of market players, increased government investment in healthcare facilities especially in rural areas, westernization in life style and dietary habits, increasing healthcare expenditure & improving medical insurance plans are driving the ablation devices market.
Report includes company profiles of major players such as Accuray (U.S.), Alcon Laboratories Inc. (U.S.), AngioDynamics Inc. (U.S.), Arthrocare Corporation (U.S.), Atricure Inc. (U.S.), Biosense Webster (U.S.), Boston Scientific (U.S.), BSD Medical Corporation (U.S.), C.R. Bard Inc. (U.S.), ConMed Corporation (U.S.), Covidien (Ireland), Elekta AB ( Sweden), Galil Medical Ltd. (Israel), Medtronic Inc. (U.S.), Misonix Inc. (U.S.), nContact Surgical Inc. (U.S.), Olympus Corporation (Japan), Smith & Nephew (U.K.), St. Jude Medical (U.S.), Urologix Inc. (U.S.) and Varian Medical Systems Inc. (U.S.).
Scope of the Report
This research report categorizes the market for ablation devices into the following segments:
Global ablation devices market, by technology
Thermal
Electrical
Radiation
Light
Radiofrequency
Ultrasound
Microwave
Hydrothermal
Non-thermal
Cryoablation
Hydromechanical
Global ablation devices market, by products
Electrical – Electrical ablators and electronic brachytherapy
Radiation – Brachytherapy, Intensity modulated radiation therapy, Image guided radiotherapy, Stereotactic Radiotherapy (SRT), Stereotactic body radiation therapy, Nano-radiation therapy and Proton beam therapy
Light – Cold lasers, Excimer lasers and ultraviolet B lasers
Radiofrequency – Temperature controlled devices, fluid cooled device and robotic navigation–catheter manipulation systems
Ultrasound – High intensity focused ultrasound, Magnetic Resonance Imaging-Guided Focused Ultrasound (MRI-FUS), Ultrasound surgical systems and shock wave therapy
Microwave – Microwave thermotherapy
Hydrothermal – Endometrial hydrothermal balloon ablation devices
Cryoablation – Tissue contact probe, cryogen spray probe and epidermal and subcutaneous cryoablation devices
Global ablation devices market, by applications
Cancer
Cardiac
Ophthalmology
Gynecology
Urology
Orthopedics
Global Surgical Equipment Industry
TABLE OF CONTENTS
1 INTRODUCTION
1.1 KEY TAKE AWAYS
1.2 REPORT DESCRIPTION
1.3 MARKETS COVERED
1.4 STAKEHOLDERS
1.5 RESEARCH METHODOLOGY
1.5.1 MARKET SIZE
1.5.2 MARKET SHARE
1.5.3 KEY DATA POINTS FROM SECONDARY SOURCES
1.5.4 KEY DATA POINTS FROM PRIMARY SOURCES
1.5.5 ASSUMPTIONS
2 EXECUTIVE SUMMARY
3 MARKET OVERVIEW
3.1 INTRODUCTION
3.2 ABLATION TECHNOLOGIES MARKET
3.3 ABLATION APPLICATION MARKET
3.4 MARKET DYNAMICS
3.4.1 DRIVERS
3.4.1.1 Technological advancements
3.4.1.2 Increasing procedures through minimal invasive surgery
3.4.1.3 Increasing aging population with higher risk of chronic diseases
3.4.2 RESTRAINTS
3.4.2.1 Pricing and reimbursement issues
3.4.2.2 Increasing regulatory agencies pressures
3.4.3 OPPORTUNITIES & CHALLENGES
3.4.3.1 Emerging markets
3.4.3.2 Technical and educational challenges
3.5 BURNING ISSUES
3.5.1 INCREASING RESEARCH IN CARDIAC ABLATION
3.6 MARKET SHARE ANALYSIS
4 ABLATION MARKET, BY TECHNOLOGY
4.1 INTRODUCTION
4.2 THERMAL
4.2.1 ELECTRICAL
4.2.2 RADIATION
4.2.3 RADIOFREQUENCY
4.2.4 LIGHT
4.2.5 ULTRASOUND
4.2.6 MICROWAVE
4.2.7 HYDROTHERMAL
4.3 NON-THERMAL
4.3.1 CRYOTHERAPY
4.3.2 HYDROMECHANICAL
5 ABLATION TECHNOLOGY MARKET, BY PRODUCTS
5.1 ELECTRICAL
5.1.1 ELECTRICAL ABLATORS
5.1.1.1 Argon Plasma/Beam coagulators
5.1.1.2 Irreversible electroporation
5.1.2 ELECTRONIC BRACHYTHERAPY
5.2 RADIATION
5.2.1 BRACHYTHERAPY
5.2.1.1 High-Dose-Rate (HDR) brachytherapy
5.2.1.2 Pulsed-Dose-Rate brachytherapy
5.2.1.3 Permanent seed brachytherapy or Low-Dose-Rate (LDR) brachytherapy
5.2.2 STEREOTACTIC RADIOSURGERY & STEREOTACTIC RADIOTHERAPY
5.2.3 IMAGE GUIDED RADIATION THERAPY (IGRT)
5.2.4 INTENSITY-MODULATED RADIATION THERAPY (IMRT)
5.2.5 STEREOTACTIC BODY RADIATION THERAPY (SBRT)
5.2.6 PROTON BEAM THERAPY
5.3 RADIOFREQUENCY
5.3.1 TEMPERATURE CONTROLLED RADIOFREQUENCY ABLATION DEVICES
5.3.2 FLUID COOLED RF ABLATION
5.3.3 THE ROBOTIC CATHETER MANIPULATION SYSTEM
5.4 LIGHT/LASER
5.4.1 COLD LASERS
5.4.2 EXCIMER LASERS
5.5 ULTRASOUND
5.5.1 HIGH INTENSITY FOCUSED ULTRASOUND (HIFU)
5.5.2 MAGNETIC RESONANCE GUIDED ULTRASOUND MRGFUS
5.5.3 ULTRASONIC SURGICAL SYSTEMS
5.5.4 EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY
5.6 MICROWAVE ABLATION
5.6.1 MICROWAVE THERMOTHERAPY
5.7 HYDROTHERMAL ABLATION
5.7.1 ENDOMETRIAL HYDROTHERMAL BALLOON ABLATION DEVICES
5.8 CRYOABLATION
5.8.1 TISSUE CONTACT PROBE
5.8.2 TISSUE SPRAY PROBE
5.8.3 EPIDERMAL AND SUBCUTANEOUS CRYOABLATION DEVICES
6 ABLATION TECHNOLOGY MARKET, BY APPLICATIONS
6.1 INTRODUCTION
6.2 CANCER
6.3 CARDIOVASCULAR
6.4 OPHTHALMOLOGY
6.5 GYNECOLOGY
6.6 UROLOGY
6.7 ORTHOPEDICS
6.8 OTHERS
7 GEOGRAPHICAL ANALYSIS
7.1 INTRODUCTION
7.2 AMERICAS
7.3 EUROPE
7.4 ASIA-PACIFIC
7.5 ROW
8 COMPETITIVE LANDSCAPE
8.1 INTRODUCTION
8.2 MERGERS & ACQUISITIONS
8.3 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, JOINT VENTURES
8.4 NEW PRODUCT LAUNCHES
8.5 PIPELINE DEVELOPMENTS
8.6 OTHER DEVELOPMENTS
9 COMPANY PROFILES
9.1 ACCURAY INC.
9.1.1 OVERVIEW
9.1.2 FINANCIALS
9.1.3 PRODUCTS & SERVICES
9.1.4 STRATEGY
9.1.5 DEVELOPMENTS
9.2 ALCON LABORATORIES INC.
9.2.1 OVERVIEW
9.2.2 FINANCIALS
9.2.3 PRODUCTS & SERVICES
9.2.4 STRATEGY
9.2.5 DEVELOPMENTS
9.3 ANGIODYNAMICS INC.
9.3.1 OVERVIEW
9.3.2 FINANCIALS
9.3.3 PRODUCTS & SERVICES
9.3.4 STRATEGY
9.3.5 DEVELOPMENTS
9.4 ARTHROCARE CORPORATION
9.4.1 OVERVIEW
9.4.2 FINANCIALS
9.4.3 PRODUCTS & SERVICES
9.4.4 STRATEGY
9.4.5 DEVELOPMENTS
9.5 ATRICURE INC.
9.5.1 OVERVIEW
9.5.2 FINANCIALS
9.5.3 PRODUCTS & SERVICES
9.5.4 STRATEGY
9.5.5 DEVELOPMENTS
9.6 BIOSENSE WEBSTER INC.
9.6.1 OVERVIEW
9.6.2 PRODUCTS & SERVICES
9.6.3 STRATEGY
9.6.4 DEVELOPMENTS
9.7 BOSTON SCIENTIFIC CORPORATION
9.7.1 OVERVIEW
9.7.2 FINANCIALS
9.7.3 PRODUCTS & SERVICES
9.7.4 STRATEGY
9.7.5 DEVELOPMENTS
9.8 BSD MEDICAL CORPORATION
9.8.1 OVERVIEW
9.8.2 FINANCIALS
9.8.3 PRODUCTS & SERVICES
9.8.4 STRATEGY
9.8.5 DEVELOPMENTS
9.9 C.R. BARD INC.
9.9.1 OVERVIEW
9.9.2 FINANCIALS
9.9.3 PRODUCTS & SERVICES
9.9.4 STRATEGY
9.9.5 DEVELOPMENTS
9.10 CONMED CORPORATION
9.10.1 OVERVIEW
9.10.2 FINANCIALS
9.10.3 PRODUCTS & SERVICES
9.10.4 STRATEGY
9.10.5 DEVELOPMENTS
9.11 COVIDIEN PLC
9.11.1 OVERVIEW
9.11.2 FINANCIALS
9.11.3 PRODUCTS & SERVICES
9.11.4 STRATEGY
9.11.5 DEVELOPMENTS
9.12 ELEKTA AB
9.12.1 OVERVIEW
9.12.2 FINANCIALS
9.12.3 PRODUCTS & SERVICES
9.12.4 STRATEGY
9.12.5 DEVELOPMENTS
9.13 GALIL MEDICAL LTD.
9.13.1 OVERVIEW
9.13.2 FINANCIALS
9.13.3 PRODUCTS & SERVICES
9.13.4 STRATEGY
9.13.5 DEVELOPMENTS
9.14 MEDTRONIC INC.
9.14.1 OVERVIEW
9.14.2 FINANCIALS
9.14.3 PRODUCTS & SERVICES
9.14.4 STRATEGY
9.14.5 DEVELOPMENTS
9.15 MISONIX INC.
9.15.1 OVERVIEW
9.15.2 FINANCIALS
9.15.3 PRODUCTS & SERVICES
9.15.4 STRATEGY
9.15.5 DEVELOPMENTS
9.16 NCONTACT SURGICAL INC.
9.16.1 OVERVIEW
9.16.2 FINANCIALS
9.16.3 PRODUCTS & SERVICES
9.16.4 STRATEGY
9.16.5 DEVELOPMENTS
9.17 OLYMPUS CORPORATION
9.17.1 OVERVIEW
9.17.2 FINANCIALS
9.17.3 PRODUCTS & SERVICES
9.17.4 STRATEGY
9.17.5 DEVELOPMENTS
9.18 SMITH & NEPHEW
9.18.1 OVERVIEW
9.18.2 FINANCIALS
9.18.3 PRODUCTS & SERVICES
9.18.4 STRATEGY
9.18.5 DEVELOPMENTS
9.19 ST. JUDE MEDICAL INC.
9.19.1 OVERVIEW
9.19.2 FINANCIALS
9.19.3 PRODUCTS & SERVICES
9.19.4 STRATEGY
9.19.5 DEVELOPMENTS
9.20 UROLOGIX INC.
9.20.1 OVERVIEW
9.20.2 FINANCIALS
9.20.3 PRODUCTS & SERVICES
9.20.4 STRATEGY
9.20.5 DEVELOPMENTS
9.21 VARIAN MEDICAL SYSTEMS INC.
9.21.1 OVERVIEW
9.21.2 FINANCIALS
9.21.3 PRODUCTS & SERVICES
9.21.4 STRATEGY
9.21.5 DEVELOPMENTS
LIST OF TABLES
TABLE 1 GLOBAL ABLATION MARKET REVENUE, BY TECHNOLOGIES, 2009 - 2016 ($MILLION)
TABLE 2 ABLATION TECHNOLOGIES MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)
TABLE 3 GLOBAL THERMAL ABLATION MARKET REVENUE, BY TECHNOLOGIES, 2009 – 2016 ($MILLION)
TABLE 4 THERMAL ABLATION TECHNOLOGIES MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)
TABLE 5 ELECTRIC ABLATION TECHNOLOGY MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)
TABLE 6 RADIATION ABLATION TECHNOLOGY MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)
TABLE 7 RADIOFREQUENCY ABLATION TECHNOLOGY MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)
TABLE 8 LIGHT/LASER ABLATION TECHNOLOGY MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)
TABLE 9 ULTRASOUND ABLATION TECHNOLOGY MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)
TABLE 10 MICROWAVE ABLATION TECHNOLOGY MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)
TABLE 11 HYDROTHERMAL ABLATION TECHNOLOGY MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)
TABLE 12 GLOBAL NON-THERMAL ABLATION MARKET REVENUE, BY TECHNOLOGIES, 2009 – 2016 ($MILLION)
TABLE 13 NON-THERMAL ABLATION TECHNOLOGIES MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)
TABLE 14 CRYOABLATION TECHNOLOGY MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)
TABLE 15 HYDROMECHANICAL ABLATION TECHNOLOGY MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)
TABLE 16 GLOBAL ELECTRICAL ABLATION MARKET REVENUE, BY PRODUCTS, 2009 – 2016 ($MILLION)
TABLE 17 GLOBAL ELECTRICAL ABLATORS MARKET REVENUE, BY PRODUCTS, 2009 - 2016 ($MILLION)
TABLE 18 GLOBAL ELECTRICAL ABLATION MARKET VOLUME, BY PRODUCTS, 2009 - 2016 (THOUSAND)
TABLE 19 GLOBAL ELECTRICAL ABLATORS MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)
TABLE 20 GLOBAL ELECTRICAL ABLATORS MARKET VOLUME, BY GEOGRAPHY, 2009 – 2016 (THOUSAND)
TABLE 21 ARGON PLASMA/BEAM COAGULATION ABLATION MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 22 ARGON PLASMA/BEAM COAGULATION ABLATION MARKET VOLUME, BY GEOGRAPHY, 2009 - 2016 (THOUSAND)
TABLE 23 IRREVERSIBLE ELECTROPORATION MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 24 IRREVERSIBLE ELECTROPORATION MARKET VOLUME, BY GEOGRAPHY, 2009 - 2016 (THOUSAND)
TABLE 25 ELECTRONIC BRACHYTHERAPY MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 26 ELECTRONIC BRACHYTHERAPY MARKET VOLUME, BY GEOGRAPHY, 2009 - 2016
TABLE 27 GLOBAL RADIATION ABLATION PRODUCTS MARKET REVENUE, BY SEGMENTS, 2009 - 2016 ($MILLION)
TABLE 28 GLOBAL RADIATION ABLATION PRODUCTS MARKET VOLUME, BY SEGMENTS, 2009 - 2016
TABLE 29 GLOBAL RADIATION ABLATION PRODUCTS MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)
TABLE 30 GLOBAL RADIATION ABLATION PRODUCTS MARKET VOLUME, BY GEOGRAPHY, 2009 – 2016
TABLE 31 GLOBAL BRACHYTHERAPY MARKET REVENUE, BY PRODUCTS, 2009 - 2016 ($MILLION)
TABLE 32 GLOBAL BRACHYTHERAPY MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)
TABLE 33 HIGH-DOSE-RATE (HDR) BRACHYTHERAPY MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 34 PULSED-DOSE-RATE (PDR) BRACHYTHERAPY MARKET REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
TABLE 35 PERMANENT SEED BRACHYTHERAPY MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 36 STEREOTACTIC RADIOSURGERY (SRS) & STEREOTACTIC RADIOTHERAPY (SRT) MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 37 STEREOTACTIC RADIOSURGERY (SRS) & STEREOTACTIC RADIOTHERAPY (SRT) MARKET VOLUME, BY GEOGRAPHY, 2009 - 2016
TABLE 38 IMAGE GUIDED RADIATION THERAPY (IGRT) MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 39 IMAGE GUIDED RADIATION THERAPY (IGRT) MARKET VOLUME, BY GEOGRAPHY, 2009 - 2016
TABLE 40 INTENSITY-MODULATED RADIATION THERAPY (IMRT) MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 41 INTENSITY-MODULATED RADIATION THERAPY (IMRT) MARKET VOLUME, BY GEOGRAPHY, 2009 - 2016
TABLE 42 STEREOTACTIC BODY RADIATION THERAPY (SBRT) MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 43 STEREOTACTIC BODY RADIATION THERAPY (SBRT) MARKET VOLUME, BY GEOGRAPHY, 2009 - 2016
TABLE 44 PROTON BEAM THERAPY MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 45 PROTON BEAM THERAPY MARKET VOLUME, BY GEOGRAPHY, 2009 - 2016
TABLE 46 GLOBAL RADIOFREQUENCY ABLATORS MARKET REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
TABLE 47 GLOBAL RADIOFREQUENCY ABLATORS MARKET VOLUME, BY SEGMENTS, 2009 - 2011 (THOUSAND)
TABLE 48 GLOBAL RADIOFREQUENCY ABLATORS MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)
TABLE 49 GLOBAL RADIOFREQUENCY ABLATORS MARKET VOLUME, BY GEOGRAPHY, 2009 – 2016 (THOUSAND)
TABLE 50 TEMPERATURE CONTROLLED ABLATORS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
TABLE 51 TEMPERATURE CONTROLLED ABLATORS MARKET VOLUME, BY GEOGRAPHY, 2009 - 2011 (THOUSAND)
TABLE 52 FLUID COOLED ABLATORS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
TABLE 53 FLUID COOLED ABLATORS MARKET VOLUME, BY GEOGRAPHY, 2009 - 2011 (THOUSAND)
TABLE 54 CATHETER MANIPULATION SYSTEMS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
TABLE 55 GLOBAL LIGHT/LASER ABLATORS MARKET REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
TABLE 56 GLOBAL LIGHT/LASER ABLATORS MARKET VOLUME, BY SEGMENTS, 2009 - 2011 (THOUSAND)
TABLE 57 LIGHT/LASER ABLATORS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
TABLE 58 LIGHT/LASER ABLATORS MARKET VOLUME, BY GEOGRAPHY, 2009 - 2011 (THOUSAND)
TABLE 59 COLD LASER ABLATORS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
TABLE 60 COLD LASER ABLATORS MARKET VOLUME, BY GEOGRAPHY, 2009 – 2011 (THOUSAND)
TABLE 61 EXCIMER LASER ABLATORS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
TABLE 62 EXCIMER LASER ABLATORS MARKET VOLUME, BY GEOGRAPHY, 2009 - 2011 (THOUSAND)
TABLE 63 GLOBAL ULTRASOUND ABLATION PRODUCTS MARKET BY REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
TABLE 64 GLOBAL ULTRASOUND ABLATION PRODUCTS MARKET BY VOLUME, BY SEGMENTS, 2009 – 2011 (THOUSAND)
TABLE 65 ULTRASOUND ABLATORS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
TABLE 66 HIGH INTENSITY FOCUSED (HIFU) ULTRASOUND ABLATORS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
TABLE 67 HIGH INTENSITY FOCUSED (HIFU) ULTRASOUND ABLATORS MARKET VOLUME, BY GEOGRAPHY, 2009 - 2011
TABLE 68 MAGNETIC RESONANCE GUIDED ULTRASOUND ABLATORS (MRG-FUS) MARKET REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
TABLE 69 MAGNETIC RESONANCE GUIDED ULTRASOUND ABLATORS (MRG-FUS) MARKET VOLUME, BY GEOGRAPHY, 2009 – 2011
TABLE 70 ULTRASONIC SURGICAL SYSTEMS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
TABLE 71 ULTRASONIC SURGICAL SYSTEMS MARKET VOLUME, BY GEOGRAPHY, 2009 - 2011 (THOUSAND)
TABLE 72 EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY (ESWL) SYSTEMS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
TABLE 73 MICROWAVE THERMOTHERAPY MARKET REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
TABLE 74 HYDROTHERMAL BALLOON ABLATION DEVICES MARKET REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
TABLE 75 HYDROTHERMAL BALLOON ABLATION DEVICES MARKET VOLUME, BY GEOGRAPHY, 2009 - 2011 (THOUSAND)
TABLE 76 GLOBAL CRYOABLATION MARKET REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
TABLE 77 GLOBAL CRYOABLATION MARKET VOLUME, BY SEGMENTS, 2009 - 2011
TABLE 78 GLOBAL CRYOABLATION MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)
TABLE 79 GLOBAL CRYOABLATION MARKET VOLUME, BY GEOGRAPHY, 2009 – 2016
TABLE 80 TISSUE CONTACT PROBE CATHETER DEVICES MARKET REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
TABLE 81 TISSUE CONTACT PROBE CATHETER MARKET VOLUME, BY GEOGRAPHY, 2009 – 2011
TABLE 82 TISSUE SPRAY PROBE CATHETER MARKET REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
TABLE 83 TISSUE SPRAY PROBE CATHETER MARKET VOLUME, BY GEOGRAPHY, 2009 – 2011
TABLE 84 EPIDERMAL & SUBCUTANEOUS CRYOABLATION DEVICES MARKET REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
TABLE 85 GLOBAL ABLATION DEVICES MARKET REVENUE, BY APPLICATIONS, 2009 - 2016 ($MILLION)
TABLE 86 FREQUENTLY USED THERAPIES FOR CANCER ABLATION
TABLE 87 CANCER ABLATION DEVICES MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 88 CARDIOVASCULAR ABLATION DEVICES MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 89 OPHTHALMOLOGY ABLATION DEVICES MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 90 GYNECOLOGY ABLATION DEVICES MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 91 UROLOGY ABLATION DEVICES MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 92 ORTHOPEDICS ABLATION DEVICES MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 93 OTHER APPLICATIONS ABLATION DEVICES MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 94 GLOBAL ABLATION TECHNOLOGIES MARKET, BY GEOGRAPHY, 2009 – 2016 ($MILLION)
TABLE 95 AMERICAS: ABLATION MARKET REVENUE, BY TECHNOLOGIES, 2009 - 2016 ($MILLION)
TABLE 96 AMERICAS: THERMAL ABLATION MARKET REVENUE, BY TECHNOLOGIES, 2009 - 2016 ($MILLION)
TABLE 97 AMERICAS: NON-THERMAL ABLATION MARKET REVENUE, BY TECHNOLOGIES, 2009 - 2016 ($MILLION)
TABLE 98 EUROPE: ABLATION MARKET REVENUE, BY TECHNOLOGIES, 2009 - 2016 ($MILLION)
TABLE 99 EUROPE: THERMAL ABLATION MARKET REVENUE, BY TECHNOLOGIES, 2009 - 2016 ($MILLION)
TABLE 100 EUROPE: NON-THERMAL ABLATION MARKET REVENUE, BY TECHNOLOGIES, 2009 - 2016 ($MILLION)
TABLE 101 ASIA–PACIFIC: ABLATION MARKET REVENUE, BY TECHNOLOGIES, 2009 - 2016 ($MILLION)
TABLE 102 ASIA-PACIFIC: THERMAL ABLATION MARKET REVENUE, BY TECHNOLOGIES, 2009 - 2016 ($MILLION)
TABLE 103 ASIA-PACIFIC: NON-THERMAL ABLATION MARKET REVENUE, BY TECHNOLOGIES, 2009 - 2016 ($MILLION)
TABLE 104 ROW: ABLATION MARKET REVENUE, BY TECHNOLOGY, 2009 - 2016 ($MILLION)
TABLE 105 ROW: THERMAL ABLATION MARKET REVENUE, BY TECHNOLOGY, 2009 - 2016 ($MILLION)
TABLE 106 ROW: NON-THERMAL ABLATION MARKET REVENUE, BY TECHNOLOGY, 2009 - 2016 ($MILLION)
TABLE 107 MERGERS & ACQUISITIONS, JANUARY 2009 – APRIL 2012
TABLE 108 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, JOINT VENTURES, JANUARY 2009 – APRIL 2012
TABLE 109 NEW PRODUCT LAUNCHES, JANUARY 2009 – APRIL 2012
TABLE 110 PIPELINE DEVELOPMENTS, JANUARY 2009 – APRIL 2012
TABLE 111 OTHER DEVELOPMENTS, JANUARY 2009 – APRIL 2012
TABLE 112 ACCURAY INC.: TOTAL REVENUE AND R&D EXPENSES, 2009 – 2011 ($MILLION)
TABLE 113 ACCURAY INC.: TOTAL REVENUE, BY SEGMENTS, 2009 – 2011 ($MILLION)
TABLE 114 ACCURAY INC.: TOTAL REVENUE, BY GEOGRAPHY, 2009 – 2011 ($MILLION)
TABLE 115 ALCON LABORATORIES INC.: TOTAL REVENUE AND R&D EXPENSES, 2008 - 2010 ($MILLION)
TABLE 116 ALCON LABORATORIES INC.: TOTAL REVENUE, BY SEGMENTS, 2008 – 2010 ($MILLION)
TABLE 117 ANGIODYNAMICS INC.: TOTAL REVENUE AND R&D EXPENSES, 2009 – 2011 ($MILLION)
TABLE 118 ANGIODYNAMICS INC.: TOTAL REVENUE, BY SEGMENTS, 2009 – 2011 ($MILLION)
TABLE 119 ANGIODYNAMICS INC.: TOTAL REVENUE, BY GEOGRAPHY, 2009 – 2011 ($MILLION)
TABLE 120 ARTHROCARE CORP: TOTAL REVENUE AND R&D EXPENSES, 2009 – 2011 ($MILLION)
TABLE 121 ARTHROCARE CORP: TOTAL REVENUE, BY SEGMENTS, 2009 – 2011 ($MILLION)
TABLE 122 ARTHROCARE CORP: TOTAL REVENUE, BY GEOGRAPHY, 2009 – 2011 ($MILLION)
TABLE 123 ATRICURE INC. : TOTAL REVENUE AND R&D EXPENSES, 2009 – 2011 ($MILLION)
TABLE 124 ATRICURE INC.: TOTAL REVENUE, BY GEOGRAPHY, 2009 – 2011 ($MILLION)
TABLE 125 BOSTON SCIENTIFIC CORP: TOTAL REVENUE AND R&D EXPENSES, 2009 – 2011 ($MILLION)
TABLE 126 BOSTON SCIENTIFIC CORPORATION : TOTAL REVENUE, BY SEGMENTS, 2009 – 2011 ($MILLION)
TABLE 127 BOSTON SCIENTIFIC CORP: TOTAL REVENUE, BY GEOGRAPHY, 2009 – 2011 ($MILLION)
TABLE 128 BSD MEDICAL CORP: TOTAL REVENUE AND R&D EXPENSES, 2009 – 2011 ($MILLION)
TABLE 129 C.R. BARD INC.: TOTAL REVENUE AND R&D EXPENSES, 2009 – 2011 ($MILLION)
TABLE 130 C.R. BARD INC. : TOTAL REVENUE, BY SEGMENTS, 2009 – 2011 ($MILLION)
TABLE 131 C.R. BARD INC.: TOTAL REVENUE, BY GEOGRAPHY, 2009 – 2011 ($MILLION)
TABLE 132 CONMED CORP: TOTAL REVENUE AND R&D EXPENSES, 2009 – 2011 ($MILLION)
TABLE 133 CONMED CORP: TOTAL REVENUE, BY SEGMENTS, 2009 – 2011 ($MILLION)
TABLE 134 CONMED CORP: TOTAL REVENUE, BY GEOGRAPHY, 2009 – 2011 ($MILLION)
TABLE 135 COVIDIEN PLC : TOTAL REVENUE AND R&D EXPENSES, 2009 – 2011 ($MILLION)
TABLE 136 COVIDIEN PLC: TOTAL REVENUE, BY SEGMENTS, 2009 – 2011 ($MILLION)
TABLE 137 COVIDIEN PLC: TOTAL REVENUE, BY GEOGRAPHY, 2009 – 2011 ($MILLION)
TABLE 138 ELEKTA AB: TOTAL REVENUE AND R&D EXPENSES, 2009 – 2011 ($MILLION)
TABLE 139 ELEKTA AB : TOTAL REVENUES, BY SEGMENTS, 2009 – 2011 ($MILLION)
TABLE 140 ELEKTA AB: TOTAL REVENUE, BY GEOGRAPHY, 2009 – 2011 ($MILLION)
TABLE 141 MEDTRONIC INC.: TOTAL REVENUE AND R&D EXPENSES, 2009 – 2011 ($MILLION)
TABLE 142 MEDTRONIC INC.: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
TABLE 143 MEDTRONIC INC.: TOTAL REVENUE, BY GEOGRAPHY, 2009 – 2011 ($MILLION)
TABLE 144 MISONIX INC. : TOTAL REVENUE AND R&D EXPENSES, 2009 – 2011 ($MILLION)
TABLE 145 MISONIX INC.: TOTAL REVENUE, BY SEGMENTS, 2009 – 2011 ($MILLION)
TABLE 146 MISONIX INC.: TOTAL REVENUE, BY GEOGRAPHY, 2009 – 2011 ($MILLION)
TABLE 147 OLYMPUS CORP: TOTAL REVENUE AND R&D EXPENSES, 2009 – 2011 ($MILLION)
TABLE 148 OLYMPUS CORP: TOTAL REVENUE, BY SEGMENTS, 2009 – 2011 ($MILLION)
TABLE 149 OLYMPUS CORP: TOTAL REVENUE, BY GEOGRAPHY, 2009 – 2011 ($MILLION)
TABLE 150 SMITH & NEPHEW: TOTAL REVENUE AND R&D EXPENSES, 2009 – 2011 ($MILLION)
TABLE 151 SMITH & NEPHEW: TOTAL REVENUE, BY SEGMENTS, 2009 – 2011 ($MILLION)
TABLE 152 SMITH & NEPHEW: TOTAL REVENUE, BY GEOGRAPHY, 2009 – 2011 ($MILLION)
TABLE 153 ST. JUDE MEDICAL INC.: TOTAL REVENUE AND R&D EXPENSES, 2009 – 2011 ($MILLION)
TABLE 154 ST. JUDE MEDICAL INC: TOTAL REVENUES, BY SEGMENTS, 2009 – 2011 ($MILLION)
TABLE 155 ST. JUDE MEDICAL INC.: TOTAL REVENUE, BY GEOGRAPHY, 2009 – 2011 ($MILLION)
TABLE 156 UROLOGIX INC.: TOTAL REVENUE AND R&D EXPENSES, 2009 – 2011 ($MILLION)
TABLE 157 UROLOGIX INC.: TOTAL REVENUE, BY SEGMENTS, 2009 – 2011 ($MILLION)
TABLE 158 VARIAN MEDICAL SYSTEMS INC.: TOTAL REVENUE AND R&D EXPENSES, 2009 – 2011 ($MILLION)
TABLE 159 VARIAN MEDICAL SYSTEMS INC.: TOTAL REVENUE, BY SEGMENTS, 2009 – 2011 ($MILLION)
TABLE 160 VARIAN MEDICAL SYSTEMS INC.: TOTAL REVENUE, BY GEOGRAPHY, 2009 – 2011 ($MILLION)
LIST OF FIGURES
FIGURE 1 GLOBAL THERMAL ABLATION TECHNOLOGIES MARKET, 2011 VS. 2016
FIGURE 2 GLOBAL NON-THERMAL ABLATION TECHNOLOGIES MARKET, 2011 VS. 2016
FIGURE 3 GRAPHICAL RANKING OF TOTAL ABLATION MARKET
FIGURE 4 ABLATION TECHNOLOGIES MARKET SEGMENTATION
FIGURE 5 MARKET SEGMENTATION OF ABLATION TECHNOLOGIES, BY APPLICATIONS
FIGURE 6 MARKET DYNAMICS
FIGURE 7 MARKET SHARE ANALYSIS, BY PLAYERS, 2011
FIGURE 8 MARKET SHARE OF ABLATION DEVICES MARKET, BY CLINICAL APPLICATIONS, 2011
FIGURE 9 STRATEGIES EMPLOYED BY MARKET PLAYERS IN CANCER ABLATION MARKET, JANUARY 2000 – MARCH 2012
FIGURE 10 TECHNOLOGIES FOCUSED BY MARKET PLAYERS FOR LAUNCHED PRODUCTS, JANUARY 2000 – MARCH 2012
FIGURE 11 TECHNOLOGIES FOCUSED BY MARKET PLAYERS FOR PRODUCTS IN PIPELINE, JANUARY 2009 – MARCH 2012
FIGURE 12 SHARE OF VARIOUS CARDIAC ABLATION PROCEDURES, 2011
FIGURE 13 STRATEGIES EMPLOYED BY THE MARKET PLAYERS IN THE CARDIAC ABLATION FIELD, JANUARY 2000 – MARCH 2012
FIGURE 14 MARKET SHARE OF ABLATION DEVICES, BY GEOGRAPHY, 2011
FIGURE 15 KEY GROWTH STRATEGIES, JANUARY 2000 – MARCH 2012
FIGURE 16 KEY PLAYERS FOCUSING ON MERGER & ACQUISITION STRATEGY, JANUARY 2000 – MARCH 2012
FIGURE 17 KEY PLAYERS FOCUSING ON PARTNERSHIPS & ALLIANCES STRATEGY, JANUARY 2000 – MARCH 2012
FIGURE 18 KEY PLAYERS FOCUSING ON NEW PRODUCT LAUNCH STRATEGY, JANUARY 2000 – MARCH 2012
FIGURE 19 KEY PLAYERS FOCUSING ON PRODUCTS IN PIPELINE, JANUARY 2009 - MARCH 2012
